Advanced science (Weinheim, Baden-Wurttemberg, Germany)
OCTN2 Activates a Non-Canonical Carnitine Metabolic Pathway to Promote MASH-HCC Progression and Immunotherapy Resistance.
Chuqi Xia, Xiao Zhang, Jinze Li, Ning Xu, Sheng Hu, Qiyu Lu, Yuxuan Li, Taifu Xiao, Xu Li, Xue Wang, Kequan Xu, Daoming Liang
Published: 202610.1002/advs.202517054
Abstract
Metabolic dysfunction-associated steatohepatitis related hepatocellular carcinoma (MASH-HCC) is a distinct HCC subtype characterized by lipid accumulation, impaired fatty acid oxidation (FAO), immune evasion, and resistance to immunotherapy. In this…
Preview only. Read the full abstract at the source